NewAmsterdam Pharma Company NV OverviewNewAmsterdam Pharma Company NV Other Income Expense Net
Other Income/Expense Net for NAMS.
Quarterly Other Income/Expense
$9.98M
↓ 66.06% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$2.44M
↓ 55.15% YoY
Trailing 12 months ending Mar 31, 2026